VANGUARD GROUP INC - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 17 filers reported holding VIRPAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$52,109
-25.9%
65,1450.0%0.00%
Q2 2023$70,357
+37.6%
65,1450.0%0.00%
Q1 2023$51,139
-53.8%
65,145
-63.3%
0.00%
Q4 2022$110,605
-74.9%
177,736
-52.1%
0.00%
Q3 2022$441,000
-23.3%
370,884
+8.5%
0.00%
Q2 2022$575,000
-24.2%
341,9770.0%0.00%
Q1 2022$759,000
-32.4%
341,977
+4.5%
0.00%
Q4 2021$1,123,000
-16.1%
327,305
+17.3%
0.00%
Q3 2021$1,339,000279,0200.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 988,165$614,9350.54%
Quantum Private Wealth, LLC 10,000$6,2230.00%
Warberg Asset Management LLC 17,012$10,5610.00%
Belpointe Asset Management LLC 19,045$11,8520.00%
OSAIC HOLDINGS, INC. 600$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$62,7440.00%
WELLS FARGO & COMPANY/MN 59$370.00%
NORTHERN TRUST CORP 15,221$9,4720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$410.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders